Arjuna Enters Strategic Collaboration With Pangaea Oncology And The Dr. Rosell Oncology Institute

The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of care

  General   Mar 31, 2026   0   8  Add to Reading List
Arjuna Enters Strategic Collaboration With Pangaea Oncology And The Dr. Rosell Oncology Institute
The research will evaluate Ag5 in treatment-resistant non-small cell lung cancer. Collaboration targets patients who have exhausted Tagrisso® or KRAS inhibitor therapy - an area of critical unmet need with no approved standard of care
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow